290 related articles for article (PubMed ID: 32635347)
21. Sirt6 stabilizes atherosclerosis plaques by promoting macrophage autophagy and reducing contact with endothelial cells.
Wang T; Sun C; Hu L; Gao E; Li C; Wang H; Sun D
Biochem Cell Biol; 2020 Apr; 98(2):120-129. PubMed ID: 31063699
[TBL] [Abstract][Full Text] [Related]
22. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
Verreth W; De Keyzer D; Davey PC; Geeraert B; Mertens A; Herregods MC; Smith G; Desjardins F; Balligand JL; Holvoet P
Br J Pharmacol; 2007 Jun; 151(3):347-55. PubMed ID: 17384667
[TBL] [Abstract][Full Text] [Related]
23. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of vasostatin-1 against atherogenesis.
Sato Y; Watanabe R; Uchiyama N; Ozawa N; Takahashi Y; Shirai R; Sato K; Mori Y; Matsuyama T; Ishibashi-Ueda H; Hirano T; Watanabe T
Clin Sci (Lond); 2018 Dec; 132(23):2493-2507. PubMed ID: 30401690
[TBL] [Abstract][Full Text] [Related]
25. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
26. CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice.
Gutiérrez-Muñoz C; Méndez-Barbero N; Svendsen P; Sastre C; Fernández-Laso V; Quesada P; Egido J; Escolá-Gil JC; Martín-Ventura JL; Moestrup SK; Blanco-Colio LM
FASEB J; 2020 Nov; 34(11):14960-14976. PubMed ID: 32924185
[TBL] [Abstract][Full Text] [Related]
27. Endothelial FN (Fibronectin) Deposition by α5β1 Integrins Drives Atherogenic Inflammation.
Al-Yafeai Z; Yurdagul A; Peretik JM; Alfaidi M; Murphy PA; Orr AW
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2601-2614. PubMed ID: 30354234
[TBL] [Abstract][Full Text] [Related]
28. Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis.
Luo Y; Duan H; Qian Y; Feng L; Wu Z; Wang F; Feng J; Yang D; Qin Z; Yan X
Cell Res; 2017 Mar; 27(3):352-372. PubMed ID: 28084332
[TBL] [Abstract][Full Text] [Related]
29. Formononetin attenuates atherosclerosis via regulating interaction between KLF4 and SRA in apoE
Ma C; Xia R; Yang S; Liu L; Zhang J; Feng K; Shang Y; Qu J; Li L; Chen N; Xu S; Zhang W; Mao J; Han J; Chen Y; Yang X; Duan Y; Fan G
Theranostics; 2020; 10(3):1090-1106. PubMed ID: 31938053
[No Abstract] [Full Text] [Related]
30. Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenase.
Sukhanov S; Snarski P; Vaughn C; Lobelle-Rich P; Kim C; Higashi Y; Shai SY; Delafontaine P
Atherosclerosis; 2015 Feb; 238(2):313-20. PubMed ID: 25549319
[TBL] [Abstract][Full Text] [Related]
31. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
[TBL] [Abstract][Full Text] [Related]
32. Varenicline aggravates atherosclerotic plaque formation in nicotine-pretreated ApoE knockout mice due to enhanced oxLDL uptake by macrophages through downregulation of ABCA1 and ABCG1 expression.
Koga M; Kanaoka Y; Okamoto M; Nakao Y; Inada K; Takayama S; Kataoka Y; Yamauchi A
J Pharmacol Sci; 2020 Jan; 142(1):9-15. PubMed ID: 31771811
[TBL] [Abstract][Full Text] [Related]
33. WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice.
Zhao Y; Liu Y; Zhang W; Xue J; Wu YZ; Xu W; Liang X; Chen T; Kishimoto C; Yuan Z
Eur J Pharmacol; 2010 Dec; 649(1-3):285-92. PubMed ID: 20868672
[TBL] [Abstract][Full Text] [Related]
34. Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE
Cheng XL; Ding F; Wang DP; Zhou L; Cao JM
Peptides; 2019 Nov; 121():170122. PubMed ID: 31386895
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of vinpocetine on the progression of atherosclerosis are mediated by Akt/NF-κB dependent mechanisms in apoE-/- mice.
Zhuang J; Peng W; Li H; Lu Y; Wang K; Fan F; Li S; Xu Y
PLoS One; 2013; 8(12):e82509. PubMed ID: 24349299
[TBL] [Abstract][Full Text] [Related]
36. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway.
Geng J; Yang C; Wang B; Zhang X; Hu T; Gu Y; Li J
Biomed Pharmacother; 2018 Jan; 97():941-947. PubMed ID: 29136772
[TBL] [Abstract][Full Text] [Related]
37. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
[TBL] [Abstract][Full Text] [Related]
38. Chondroitin Sulfate
Adhikara IM; Yagi K; Mayasari DS; Suzuki Y; Ikeda K; Ryanto GRT; Sasaki N; Rikitake Y; Nadanaka S; Kitagawa H; Miyata O; Igarashi M; Hirata KI; Emoto N
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1076-1091. PubMed ID: 33504177
[TBL] [Abstract][Full Text] [Related]
39. (-)-Epicatechin gallate blocks the development of atherosclerosis by regulating oxidative stress
Yu J; Li W; Xiao X; Huang Q; Yu J; Yang Y; Han T; Zhang D; Niu X
Food Funct; 2021 Sep; 12(18):8715-8727. PubMed ID: 34365492
[TBL] [Abstract][Full Text] [Related]
40. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M
Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
